source
- Experts warn of safety risks as FDA targets compounded GLP-1 weight-loss drugs sold by telehealth firmsAt the HLTH conference, experts highlighted growing concerns about telehealth companies that sell compounded GLP-1 weight-loss medications. These firms create custom formulations and ship them dir…
- Crown Biosciences remains independent after $204 million Adicon acquisition collapsesCrown Biosciences, a contract research organization, will continue operating on its own after a planned sale to China's Adicon did not close. The parties announced on Nov 16 that they were ending…